Sign In

Sanne Weijzen

COO at Scenic Biotech

Professional Background

Sanne Weijzen is a highly accomplished professional in the field of cancer immunology and tumor biology, holding an impressive array of leadership roles in various organizations throughout her career. Currently, she serves as the Chief Operating Officer (COO) at Scenic Biotech, where she leverages her extensive knowledge and expertise to drive innovations in healthcare and biotechnology. With a firm background in academia and industry, Sanne has established herself as a pivotal figure in the biomedical field.

Prior to her role at Scenic Biotech, Sanne operated as a business owner at CoMetis, where she played a critical role in providing strategic insights and advancing their operational objectives. Her experience extends to significant positions in various boards, including her tenure as both Ad-interim Chairman of the Supervisory Board and as a Member of the Supervisory Board at InteRNA Technologies BV. During this time, Sanne contributed her expertise in guiding the company’s oversight and strategic direction, focusing on advancing therapeutic solutions for cancer treatment.

With an impressive history at Aglaia BioMedical Ventures, Sanne excelled as a Partner and Investment Manager, where she was responsible for making key investment decisions that fostered growth and innovation in the biomedical sector. Her initial stint at Aglaia as a Business Analyst further honed her analytical skills, enabling her to assess market opportunities accurately and contribute to strategic planning.

Adding to her rich professional tapestry, Sanne has also worked as a post-doctoral researcher in the Department of Physiological Chemistry at UMC Utrecht, showcasing her foundational expertise in scientific research and a deep understanding of the complexities involved in cancer biology.

Collectively, Sanne Weijzen’s professional journey demonstrates her commitment to advancing cancer research and therapeutic development, combined with her robust management capabilities.

Education and Achievements

Sanne’s educational background is as impressive as her professional career. She pursued her PhD in Cancer Immunology and Tumor Biology at Loyola University Chicago in partnership with Universiteit Leiden, where she engaged in groundbreaking research that contributed significantly to the field of cancer treatment. This achievement not only signifies her dedication to understanding the immune system's role in combating cancer but also reflects her drive to translate scientific knowledge into clinical applications.

Additionally, Sanne holds a Master’s degree in Biomedical Sciences from Leiden University, which laid the groundwork for her extensive understanding of complex biological systems and biomedical research. Her educational accolades underscore her commitment to continuous learning and scientific advancement, enabling her to stay at the forefront of medical innovations.

Sanne Weijzen is not only a leader in her professional domain but also an exemplification of how academic rigor paired with practical experience can yield significant advancements in healthcare. Her journey is a testament to her passion for improving patient outcomes through diligent research and thoughtful leadership in the biotech sector.

Achievements

  • Chief Operating Officer (COO) at Scenic Biotech: Spearheading operational efforts to enhance the company’s innovation and growth in the biotech sector.
  • Owner of CoMetis: Founded and operated a business focused on leveraging scientific and business acumen to drive advancements.
  • Chair and Member of Supervisory Board, InteRNA Technologies BV: Provided leadership and strategic guidance to steer company initiatives and oversee crucial developments in cancer therapeutics.
  • Partner and Investment Manager at Aglaia BioMedical Ventures: Played a critical role in decision-making for investments in promising biomedical startups.
  • Post-doctoral Researcher at UMC Utrecht: Conducted research in physiological chemistry, contributing to the understanding of disease mechanisms and potential therapies.

Related Questions

How did Sanne Weijzen's research during her PhD impact the field of cancer immunology?
What leadership strategies does Sanne Weijzen employ in her role as COO at Scenic Biotech?
In what ways did Sanne Weijzen's experience at Aglaia BioMedical Ventures shape her approach to investments in biotechnology?
What significant contributions did Sanne Weijzen make during her tenure at InteRNA Technologies BV?
How has Sanne Weijzen's background in biomedical sciences influenced her career trajectory and success in the biotechnology industry?
Sanne Weijzen
Add to my network

Location

The Randstad, Netherlands